The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Sepsis and the Heart
Abstract
Sepsis is generally viewed as a disease aggravated by an inappropriate immune response encountered in the afflicted individual. As an important organ system frequently compromised by sepsis and always affected by septic shock, the cardiovascular system and its dysfunction during sepsis have been studied in clinical and basic research for more than 5 decades. Although a number of mediators and pathways have been shown to be associated with myocardial depression in sepsis, the precise cause remains unclear to date. There is currently no evidence supporting global ischemia as an underlying cause of myocardial dysfunction in sepsis; however, in septic patients with coexistent and possibly undiagnosed coronary artery disease, regional myocardial ischemia or infarction secondary to coronary artery disease may certainly occur. A circulating myocardial depressant factor in septic shock has long been proposed, and potential candidates for a myocardial depressant factor include cytokines, prostanoids, and nitric oxide, among others. Endothelial activation and induction of the coagulatory system also contribute to the pathophysiology in sepsis. Prompt and adequate antibiotic therapy accompanied by surgical removal of the infectious focus, if indicated and feasible, is the mainstay and also the only strictly causal line of therapy. In the presence of severe sepsis and septic shock, supportive treatment in addition to causal therapy is mandatory. The purpose of this review is to delineate some characteristics of septic myocardial dysfunction, to assess the most commonly cited and reported underlying mechanisms of cardiac dysfunction in sepsis, and to briefly outline current therapeutic strategies and possible future approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Profound but Reversible Myocardial Depression in Patients with Septic Shock
PARKER, M. M., SHELHAMER, J. H., BACHARACH, S. L., GREEN, M. V., NATANSON, C., FREDERICK, T. M., DAMSKE, B. A., & PARRILLO, J. E. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-4-483 · Cited by 1,585
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,179
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,102
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Endotoxemia in Human Septic Shock
Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M., & Parillo, J. E. (1991) · Chest · doi:10.1378/chest.99.1.169 · Cited by 656
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Parrillo, J. E., Burch, C., Shelhamer, J. H., Parker, M. M., Natanson, C., & Schuette, W. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112135 · Cited by 620
Schulz, R., Nava, E., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09021.x · Cited by 612
Red blood cells express a functional endothelial nitric oxide synthase
Kleinbongard, P. (2006) · Blood · doi:10.1182/blood-2005-10-3992 · Cited by 568
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 521
van der Poll, T., Coyle, S. M., Barbosa, K., Braxton, C. C., & Lowry, S. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118469 · Cited by 519
PARKER, M. M., SHELHAMER, J. H., NATANSON, C., ALLING, D. W., & PARRILLO, J. E. (1987) · Critical Care Medicine · doi:10.1097/00003246-198710000-00006 · Cited by 505
The coronary circulation in human septic shock.
Cunnion, R. E., Schaer, G. L., Parker, M. M., Natanson, C., & Parrillo, J. E. (1986) · Circulation · doi:10.1161/01.cir.73.4.637 · Cited by 474
Nitric oxide in myocardial ischemia/reperfusion injury
Schulz, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.019 · Cited by 462
Peroxynitrite Is a Major Contributor to Cytokine-Induced Myocardial Contractile Failure
Ferdinandy, P., Danial, H., Ambrus, I., Rothery, R. A., & Schulz, R. (2000) · Circulation Research · doi:10.1161/01.res.87.3.241 · Cited by 457
Padkin, A., Goldfrad, C., Brady, A. R., Young, D., Black, N., & Rowan, K. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000085141.75513.2b · Cited by 454
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Self-citationPrior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M., Zeller, L., & Danon, A. (2004) · Circulation · doi:10.1161/01.cir.0000138932.17956.f1 · Cited by 402
Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145229.59014.6c · Cited by 387
Parker, M. M., McCarthy, K. E., Ognibene, F. P., & Parrillo, J. E. (1990) · Chest · doi:10.1378/chest.97.1.126 · Cited by 382
Dhainaut, J. F., Huyghebaert, M. F., Monsallier, J. F., Lefevre, G., Dall'Ava-Santucci, J., Brunet, F., Villemant, D., Carli, A., & Raichvarg, D. (1987) · Circulation · doi:10.1161/01.cir.75.3.533 · Cited by 378
Elevation of troponin I in sepsis and septic shock
Ammann, P., Fehr, T., Minder, E., Günter, C., & Bertel, O. (2001) · Intensive Care Medicine · doi:10.1007/s001340100920 · Cited by 367
Sepsis/septic shock: Participation of the microcirculation
Hinshaw, L. B. (1996) · Critical Care Medicine · doi:10.1097/00003246-199606000-00031 · Cited by 350
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348
Biochemistry of Mitochondrial Nitric-oxide Synthase
Elfering, S. L., Sarkela, T. M., & Giulivi, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205256200 · Cited by 347
The Effect of Statins on Mortality in Patients with Bacteremia
Liappis, A. P., Kan, V. L., Rochester, C. G., & Simon, G. L. (2001) · Clinical Infectious Diseases · doi:10.1086/323334 · Cited by 338
Cardiac Troponins I and T Are Biological Markers of Left Ventricular Dysfunction in Septic Shock
ver Elst, K. M., Spapen, H. D., Nguyen, D. N., Garbar, C., Huyghens, L. P., & Gorus, F. K. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.650 · Cited by 321
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Hackam, D. G., Mamdani, M., Li, P., & Redelmeier, D. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68041-0 · Cited by 321
Sepsis-Associated Myocardial Dysfunction
Maeder, M., Fehr, T., Rickli, H., & Ammann, P. (2006) · Chest · doi:10.1378/chest.129.5.1349 · Cited by 310
Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298
Fukuta, H., Sane, D. C., Brucks, S., & Little, W. C. (2005) · Circulation · doi:10.1161/circulationaha.104.519876 · Cited by 294
Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity
del Real, G., Jiménez-Baranda, S., Mira, E., Lacalle, R. A., Lucas, P., Gómez-Moutón, C., Alegret, M., Peña, J. M., Rodríguez-Zapata, M., Alvarez-Mon, M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040061 · Cited by 294
Statin treatment after onset of sepsis in a murine model improves survival.
Merx, M. W., Liehn, E. A., Graf, J., van de Sandt, A., Schaltenbrand, M., Schrader, J., Hanrath, P., & Weber, C. (2005) · Circulation · doi:10.1161/circulationaha.104.502195 · Cited by 287
Self-citationHMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis
Merx, M. W., Liehn, E. A., Janssens, U., Lütticken, R., Schrader, J., Hanrath, P., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000129774.09737.5b · Cited by 277
Self-citationInfusion of methylene blue in human septic shock: A pilot, randomized, controlled study
Kirov, M. Y., Evgenov, O. V., Evgenov, N. V., Egorina, E. M., Sovershaev, M. A., Sveinbjørnsson, B., Nedashkovsky, E. V., & Bjertnaes, L. J. (2001) · Critical Care Medicine · doi:10.1097/00003246-200110000-00002 · Cited by 265
Natanson, C., Fink, M. P., Ballantyne, H. K., MacVittie, T. J., Conklin, J. J., & Parrillo, J. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112559 · Cited by 257
Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock
Mehta, N. J., Khan, I. A., Gupta, V., Jani, K., Gowda, R. M., & Smith, P. R. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.02.005 · Cited by 231
Myocardial cell injury in septic shock
Turner, A., Tsamitros, M., & Bellomo, R. (1999) · Critical Care Medicine · doi:10.1097/00003246-199909000-00012 · Cited by 230
Administration of Anti-TNF Antibody Improves Left Ventricular Function in Septic Shock Patients
Vincent, J.-L., Bakker, J., Marécaux, G., Schandene, L., Kahn, R. J., & Dupont, E. (1992) · Chest · doi:10.1378/chest.101.3.810 · Cited by 220
BACTEREMIA DUE TO GRAM-NEGATIVE BACILLI OTHER THAN THE SALMONELLA: A Clinical and Therapeutic Study
WAISBREN, B. A. (1951) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1951.03810100051005 · Cited by 209
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
Tonelli, M., Isles, C., Craven, T., Tonkin, A., Pfeffer, M. A., Shepherd, J., Sacks, F. M., Furberg, C., Cobbe, S. M., Simes, J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.517565 · Cited by 197
Evidence of myocardial hibernation in the septic heart*
Levy, R. J., Piel, D. A., Acton, P. D., Zhou, R., Ferrari, V. A., Karp, J. S., & Deutschman, C. S. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000189943.60945.77 · Cited by 196
Elevated Cardiac Troponin Measurements in Critically Ill Patients
Lim, W. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2446 · Cited by 195
Bone, R. C. (1991) · Chest · doi:10.1378/chest.100.3.802 · Cited by 193
Yoshida, M., Sawada, T., Ishii, H., Gerszten, R. E., Rosenzweig, A., Gimbrone, M. A., Yasukochi, Y., & Numano, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092143 · Cited by 187
Yang, L. L., Gros, R., Kabir, M. G., Sadi, A., Gotlieb, A. I., Husain, M., & Stewart, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000105701.98663.d4 · Cited by 177
Reilly, J. M., Cunnion, R. E., Burch-Whitman, C., Parker, M. M., Shelhamer, J. H., & Parrillo, J. E. (1989) · Chest · doi:10.1378/chest.95.5.1072 · Cited by 170
Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*
Suzuki, T., Morisaki, H., Serita, R., Yamamoto, M., Kotake, Y., Ishizaka, A., & Takeda, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000182796.11329.3b · Cited by 166
Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis
Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., & Balligand, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.005 · Cited by 164
Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice
Connelly, L., Madhani, M., & Hobbs, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411991200 · Cited by 153
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats
Khadour, F., Panas, D. L., Ferdinandy, P., Schulze, C. J., Csont, T., Lalu, M. M., Wildhirt, S. M., & Schulz, R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00549.2001 · Cited by 153
Ullrich, R., Scherrer‐Crosbie, M., Bloch, K. D., Ichinose, F., Nakajima, H., Picard, M. H., Zapol, W. M., & Quezado, Z. (2000) · Circulation · doi:10.1161/01.cir.102.12.1440 · Cited by 148
Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo
Steiner, S., Speidl, W. S., Pleiner, J., Seidinger, D., Zorn, G., Kaun, C., Wojta, J., Huber, K., Minar, E., Wolzt, M., et al. (2005) · Circulation · doi:10.1161/01.cir.0000158665.27783.0c · Cited by 145
Endogenous Nitric Oxide and Myocardial Adaptation to Ischemia
Heusch, G., Post, H., Michel, M. C., Kelm, M., & Schulz, R. (2000) · Circulation Research · doi:10.1161/01.res.87.2.146 · Cited by 145
Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated Cardiomyopathy
Francis, S., Holden, H. M., Holt, C. M., & Duff, G. W. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0592 · Cited by 141
Corticosteroids for septic shock
Annane, D. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00036 · Cited by 126
Diastolic filling in human severe sepsis
Munt, B. I., Jue, J., Gin, K., Fenwick, J. C., & Tweeddale, M. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00023 · Cited by 121
Rhodes, A., Lamb, F. J., Malagon, I., Newman, P. J., Grounds, R. M., & Bennett, E. D. (1999) · Critical Care Medicine · doi:10.1097/00003246-199911000-00007 · Cited by 117
Zeiher, B. G., Steingrub, J. H., Laterre, P., Dmitrienko, A. A., Fukiishi, Y., & Abraham, E. H. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171540.54520.69 · Cited by 114
Zhang, L., Zhang, Z. G., Ding, G., Jiang, Q., Liu, X., Meng, H., Hozeska‐Solgot, A., Zhang, C., Li, L., Morris, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.516757 · Cited by 107
Positive effects of nitric oxide on left ventricular function in humans
Rassaf, T. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl096 · Cited by 103
An Assessment of Myocardial Function in Human Sepsis Utilizing ECG Gated Cardiac Scintigraphy
Calvin, J. E., Driedger, A. A., & Sibbald, W. J. (1981) · CHEST Journal · doi:10.1378/chest.80.5.579 · Cited by 101
Liu, S. F., Newton, R. C., Evans, T. W., & Barnes, P. J. (1996) · Clinical Science · doi:10.1042/cs0900301 · Cited by 101
Kurakata, S., Kada, M., Shimada, Y., KOMAI, T., & Nomoto, K. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00108-7 · Cited by 99
Hoffman, J., Werdan, K., Hartl, W. H., Jochum, M., Faist, E., & Inthorn, D. (1999) · Shock · doi:10.1097/00024382-199909000-00002 · Cited by 81
Oxygen free radicals: Effect on red cell deformability in sepsis
POWELL, R. J., MACHIEDO, G. W., RUSH, B. F., & DIKDAN, G. (1991) · Critical Care Medicine · doi:10.1097/00003246-199105000-00022 · Cited by 80
Kelm, M., Schäfer, S., Dahmann, R., Dolu, B., Perings, S. M., Decking, U. K. M., Schrader, J., & Strauer, B. E. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00149-1 · Cited by 80
Reddy, R. C., Chen, G. H., Tateda, K., Tsai, W. C., Phare, S. M., Mancuso, P., Peters-Golden, M. L., & Standiford, T. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.3.l537 · Cited by 64
Erkkilä, L., Jauhiainen, M., Laitinen, K., Haasio, K., Tiirola, T. M., Saikku, P., & Leinonen, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3959-3962.2005 · Cited by 61
Epinephrine Exerts Anticoagulant Effects during Human Endotoxemia
van der Poll, T., Levi, M. M., Dentener, M. A., Jansen, P. M., Coyle, S. M., Braxton, C. C., Buurman, W. A., Hack, C. E., ten Cate, J. W., & Lowry, S. F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1143 · Cited by 59
Nitric oxide modulation of TNF-α-induced cardiac contractile dysfunction is concentration dependent
Horton, J. W., Maass, D. L., White, J., & Sanders, B. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1955 · Cited by 59
Merx, M. W., Gödecke, A., Flögel, U., & Schrader, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2886fje · Cited by 56
Self-citationEffects of lornoxicam on the physiology of severe sepsis
Memiş, D., Karamanlıoğlu, B., Turan, A., Koyuncu, O., & Pamukçu, Z. (2004) · Critical Care · doi:10.1186/cc2969 · Cited by 54
Myocardial oxygen extraction ratio is decreased during endotoxemia in pigs
Herbertson, M., Werner, H., Russell, J. A., et al. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.2.479 · Cited by 54
Upregulation of Endothelin-1 and Adrenomedullin Gene Expression in the Mouse Endotoxin Shock Model
Shindo, T., Kurihara, H., Kurihara, Y., Morita, H., & Yazaki, Y. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800001-00156 · Cited by 50
Raeburn, C. D., Calkins, C. M., Zimmerman, M. A., Song, Y., Ao, L., Banerjee, A. M., Meng, X., & Harken, A. H. (2001) · Surgery · doi:10.1067/msy.2001.116410 · Cited by 45
High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats
van Lambalgen, A. A., van Kraats, A. A., Mulder, M. F., Teerlink, T., & van den Bos, G. C. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.4.h1581 · Cited by 40
Ferri, L. E., Swartz, D., & Christou, N. V. (2001) · Critical Care Medicine · doi:10.1097/00003246-200101000-00024 · Cited by 37
MYOCARDIAL DYSFUNCTION IN THE SEPTIC RAT HEART: ROLE OF NITRIC OXIDE
McDonough, K. H., Smith, T. W., Patel, K., & Quinn, M. (1998) · Shock · doi:10.1097/00024382-199811000-00011 · Cited by 34
Nevière, R., Guery, B. P., Mordon, S. R., Zerimech, F., Charré, S., Wattel, F., & Chopin, C. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1783 · Cited by 34
Statins: a preventive strike against sepsis in patients with cardiovascular disease?
Merx, M. W., & Weber, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68042-2 · Cited by 25
Self-citationDobutamine does not influence inflammatory pathways during human endotoxemia*
Lemaire, L. C. J. M., de Kruif, M. D., Giebelen, I. A. J., Levi, M. M., van der Poll, T., & Heesen, M. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000215514.96888.e3 · Cited by 23
Chronic peritoneal sepsis: myocardial dysfunction, endothelin and signaling mechanisms
Gupta, A. (2005) · Frontiers in bioscience · doi:10.2741/1774 · Cited by 10
Cited by
Human serum albumin, systemic inflammation, and cirrhosis
Arroyo, V., García-Martinez, R., & Salvatella, X. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.012 · Cited by 560
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders
Dinda, B., Dinda, S., DasSharma, S., Banik, R., Chakraborty, A., & Dinda, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.004 · Cited by 541
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Bader, F., Manla, Y., Atallah, B., & Starling, R. C. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10008-2 · Cited by 259
Metadata
- Authors
- Merx, M. W., & Weber, C.
- Venue
- Circulation
- Published
- 2007-08-14
- Volume
- 116
- Issue
- 7
- Pages
- 793-802
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1988289466
- Cited by
- 603
- References
- 104
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.